Did you know, it is predicted that myopia alone will impact nearly half the global population by 2050? With that in mind, Zhaoke Ophthalmology has developed a new innovative drug, NVK002, that seeks to address this concern.
Join in the conversation with Dan Koh and Zia-ul Raushan as they invite Lisa Feng, CFO, Zhaoke Ophthalmology on today’s episode of Money and Me to talk about what her company is doing to position themselves as a market leader in this space and the opportunities presented to investors looking to dabble in the world of eye health.

Money and Me: He got out of $740k debt with this system and says any investor can use it
25:53

Market View: Tesla’s $25B Bet, Oil at $100, and the Battery Disruption Ahead
24:04

Money and Me: Investing Beyond Earth
22:48